IM Cannabis Corp. Receives Nasdaq Minimum Bid Price Notification Amidst Growth and Challenges #NASDAQ #Canada #Toronto #cannabis_industry #IM_Cannabis
IM Cannabis Corp's 2025 Financial Report Reveals Major Growth in Germany and Positive Cash Flow #medical_cannabis #IM_Cannabis #Germany_growth
IM Cannabis Corp. Expands Into Defense Technology with Acquisition Plans #USA #Toronto #Defense_Technology #IM_Cannabis #Blackaxe_Tech
IM Cannabis Secures Over $2 Million in Financing for Growth and Stability #USA #Toronto #medical_cannabis #IM_Cannabis #Note_Purchase_Agreements
IM Cannabis Expands Leadership with Appointment of Alon Dayan to Board #Israel #Toronto #medical_cannabis #IM_Cannabis #Alon_Dayan
IM Cannabis Eyes U.S. Market Following Trump's Executive Order on Medical Marijuana #USA #Toronto #medical_cannabis #U.S._Market #IM_Cannabis
IM Cannabis Announces Asi Levi as New CFO to Enhance Financial Direction #Canada #CFO #Toronto #IM_Cannabis #Asi_Levi
IM Cannabis Corp. Reveals Third Quarter 2025 Financial Performance Insights #Canada #Toronto #cannabis_industry #IM_Cannabis #Nasdaq_IMCC
IM Cannabis Corp. Scheduled to Announce Q3 2025 Financial Results on November 13th #Israel #earnings_report #medical_cannabis #IM_Cannabis #Glil_Yam
IM Cannabis Announces Departure of CFO Uri Birenberg in Transition Phase #USA #Toronto #CFO_Transition #IM_Cannabis #Uri_Birenberg
IM Cannabis Expands Bio Data Capabilities with Major Quantum Computing Acquisition #Canada #Quantum_Computing #Toronto #IM_Cannabis #Bio_Data
IM Cannabis Corp. Announces Board Restructuring and New Business Strategy Exploration #Canada #Toronto #IM_Cannabis #Shmulik_Arbel #Eli_Zamir
IM Cannabis Successfully Regains Nasdaq Compliance for Stockholders' Equity Requirement #USA #Toronto #IM_Cannabis #Nasdaq_IMCC #Israeli_cannabis
IM Cannabis Reveals Warrant Amendment and SEC Filing Details #Canada #Toronto #SEC_Filing #IM_Cannabis #Warrant_Amendments
IM Cannabis Corporation Demonstrates Strong Financial Resilience Amid Revenue Challenges in Q2 2025 #USA #Toronto #medical_cannabis #IM_Cannabis #profitability_growth
IM Cannabis Corp. to Unveil Financial Results for Q2 2025 on August 12 #None #Israel #medical_cannabis #IM_Cannabis
IM Cannabis Successfully Completes Private Placement Raising Approximately $4.1 Million #Canada #Toronto #fundraising #medical_cannabis #IM_Cannabis
IM Cannabis Expands Leadership and Secures $2 Million Loan Agreement #Canada #Toronto #IM_Cannabis #loan_agreement #Oz_Adler
IM Cannabis Corp. Updates Stakeholders on Nasdaq Compliance and Future Plans #USA #NASDAQ #Toronto #Compliance #IM_Cannabis
IM Cannabis Corp. Announces Intent to Voluntarily Delist from CSE to Streamline Operations #None #NASDAQ #IM_Cannabis #CSE
IM Cannabis Corp. Reports Significant Corporate Developments and Financial Restructuring Strategies #Canada #Israel #Toronto #medical_cannabis #IM_Cannabis
IM Cannabis Corp. Reports Positive Financial Performance in Q1 2025 #Canada #Toronto #medical_cannabis #Q1_2025 #IM_Cannabis
IM Cannabis Files Information Circular for Shareholder Meeting Scheduled in May 2025 #Canada #Toronto #shareholder_meeting #IM_Cannabis #Focus_Transaction
IM Cannabis Corp. Posts Corporate Developments Amid Regulatory Compliance Challenges #NASDAQ #Canada #Toronto #IM_Cannabis #Focus_Medical
IM Cannabis Reports Robust Financial Results for Q4 and Full Year 2024 With Notable Revenue Growth and Decreased Expenses #None #financial_results #medical_cannabis #IM_Cannabis